Masnavi Capital
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Biotechnology, Financial Services, Food and Beverage, Health Care, Information Technology, Medical, Software
Stage Focus
Seed
Geographical Focus
United States, United Kingdom, Germany, Singapore, Ukraine
Industries Focus
- Financial Services
- Software
- Credit
- Consumer
- FinTech
- Health Care
- Food and Beverage
- InsurTech
- Information Technology
- Biotechnology
- Big Data
- Life Science
- Therapeutics
- Medical
- Consumer Lending
Investment Size:
1,000,000 to 2,000,000 USD
Investor Details Founded: 2020
Masnavi Capital is a venture capital firm based in Kyiv, Ukraine, focusing on seed-stage investments in sectors such as biotechnology, financial services, food and beverage, health care, information technology, medical, and software. The firm has a geographical focus on North America and Europe, with investments in the United States, Germany, the United Kingdom, Singapore, and Ukraine.
Masnavi Capital's investment stages include seed, early-stage venture, late-stage venture, and convertible notes. The firm's portfolio companies include Orbillion Bio, 100Plus, Boundary Layer Technologies, atai Life Sciences, and Credolab. Notable exits include atai Life Sciences and 100Plus. The firm is led by founder A. K. and operates with a team of 1-10 employees.
Requirements
- Impact-oriented startups
- Early-stage companies
- Companies in biotechnology, financial services, food and beverage, health care, information technology, medical, and software sectors
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Orbillion Bio
- 100Plus
- Boundary Layer Technologies
- ATAI Life Sciences
- Credolab
Mentioned In
-
$49.95
-
$24.95
-
$14.95
-
$19.95
-
$24.95
-
$99.00
Claim this Investor
Are you an official representative of Masnavi Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim